Back
KLA Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
68
KLAC
KLA
Last Price:
816.53
Seasonality Move:
1.95%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Buy
68
KLA (KLAC)
is a Buy
Is KLA a Buy, Sell or Hold?
- The current KLA [KLAC] share price is $829.49. The Score for KLAC is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- KLAC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KLAC Stock Price Chart
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $38.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
KLAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 29.29 | Buy |
| Relative Strength Index (14 RSI): | 62.1 | Buy |
| Chaikin Money Flow: | -860806 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (754.08 - 818.26) | Buy |
| Bollinger Bands (100): | (645.06 - 762.52) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 40.05 | Sell |
| Chaikin Money Flow: | 76134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.06 - 42.34) | Sell |
| Bollinger Bands (100): | (41.13 - 48.85) | Sell |
KLAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 827.12 | Buy |
| 20-day SMA: | 792.97 | Buy |
| 50-day SMA: | 736.28 | Buy |
| 200-day SMA: | 612.87 | Buy |
| 8-day EMA: | 826.42 | Buy |
| 20-day EMA: | 797.13 | Buy |
| 50-day EMA: | 753.27 | Buy |
| 200-day EMA: | 636.16 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.68 | Sell |
| 20-day SMA: | 40.48 | Sell |
| 50-day SMA: | 42.18 | Sell |
| 200-day SMA: | 42.45 | Sell |
| 8-day EMA: | 39.81 | Sell |
| 20-day EMA: | 40.64 | Sell |
| 50-day EMA: | 42.13 | Sell |
| 200-day EMA: | 43.5 | Sell |
KLA Earnings Growth & KLAC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.18 per share, an increase next quarter of $0.21 per share, a decrease this year of $1.40 per share, and an increase next year of $5.22 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
KLA Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||